Financial Performance - Operating revenue for the first quarter was CNY 41,633,208.91, representing a decline of 44.70% year-on-year[9]. - Net profit attributable to shareholders was CNY 623,256.83, down 77.65% from the same period last year[9]. - Basic and diluted earnings per share were CNY 0.0051, a decrease of 77.73% compared to the previous year[9]. - Total operating revenue for the current period is CNY 41,633,208.91, a decrease of 44.7% compared to CNY 75,291,438.65 in the previous period[26]. - Total operating costs for the current period amount to CNY 44,841,012.77, down 42.0% from CNY 77,361,252.64 in the previous period[26]. - Operating profit for the current period is CNY -903,666.02, compared to CNY 2,700,634.92 in the previous period, indicating a significant decline[27]. - Net profit for the current period is CNY -78,911.00, a decrease from CNY 2,608,072.31 in the previous period[27]. - The company reported an investment loss of CNY -27,139,670.75 for the current period, compared to a gain of CNY 4,770,448.91 in the previous period[29]. Cash Flow - Cash flow from operating activities generated CNY 916,793.46, a significant improvement from a negative cash flow of CNY -3,906,229.45 in the same period last year[9]. - Net cash flow from operating activities improved by 123.47% to ¥916,793.46 from -¥3,906,229.45, as cash inflows exceeded outflows this year[15]. - Total cash inflow from operating activities was 33,595,155.48, while cash outflow was 32,678,362.02, resulting in a net increase[32]. - Cash inflow from financing activities was 3,621,688.83, while cash outflow totaled 1,599,225.67, leading to a net cash flow of 2,022,463.16[33]. - Cash flow from investment activities showed a net outflow of 9,912,792.53, compared to a net inflow of 3,760,622.41 in the previous period[33]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 320,825,359.24, a decrease of 1.16% compared to the end of the previous year[9]. - Total assets decreased to ¥320,825,359.24 from ¥324,583,812.61, reflecting a slight decline in overall asset value[19]. - Total liabilities decreased to ¥222,728,863.24 from ¥226,408,405.61, indicating a reduction in the company's debt levels[20]. - Total liabilities are CNY 120,342,316.87, an increase from CNY 113,535,443.27 in the previous period[24]. - Owner's equity totals CNY 58,798,365.21, down from CNY 72,810,033.24 in the previous period[24]. Shareholder Information - The total number of shareholders at the end of the reporting period was 8,374[12]. - The top ten shareholders held a combined 49.80% of the company's shares, with Tianjin Changhui Investment Management Partnership holding 8.20%[12]. Other Income and Expenses - The company received government subsidies amounting to CNY 1,689,647.86 during the reporting period[10]. - The company reported a total of CNY 153,408.86 in net income after accounting for non-recurring items[10]. - Revenue from non-operating income increased significantly by 1,228.92% to ¥1,865,918.38 from ¥140,408.80, mainly due to increased compensation for business suspension and demolition in Huangshan[15].
*ST目药(600671) - 2014 Q1 - 季度财报